The dynamics of colorectal cancer management in 17 countries

European Journal of Health Economics

Volumn 10, Issue SUPPL. 1, 2009, Pages

  Kanavos, Panos ^a   Schurer, Willemien ^a  

^a LONDON SCHOOL OF ECONOMICS   (United Kingdom)

Author keywords

Access; Affordability; Availability; Cancer management; Colorectal cancer; Health policy; Health technology assessment; Practice guidelines; Quality of care; Screening

Indexed keywords

BEVACIZUMAB; CAPECITABINE; CETUXIMAB; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; TEGAFUR; URACIL;

AUSTRALIA; AWARENESS; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER SURGERY; CLINICAL PRACTICE; COLORECTAL CANCER; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; CZECH REPUBLIC; DISEASE SEVERITY; EVIDENCE BASED PRACTICE; FINLAND; FRANCE; GASTROINTESTINAL ENDOSCOPY; GERMANY; HEALTH CARE ACCESS; HEALTH CARE MANAGEMENT; HEALTH CARE POLICY; HEALTH CARE QUALITY; HUMAN; ITALY; NETHERLANDS; PHARMACEUTICAL CARE; POLAND; PRIORITY JOURNAL; RUSSIAN FEDERATION; SPAIN; SWEDEN; UNITED KINGDOM; UNITED STATES;

EID: 76649117725     PISSN: 16187598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10198-009-0201-2     Document Type: Conference Paper

References (87)

1. Ferlay, J., Autier, P., Boniol, M., et al.: Estimates of the cancer incidence and mortality in Europe in 2006. Ann. Oncol. (2007)
2. Verdecchia, A., Francisci, S., Brenner, H., et al.: Recent cancer survival in Europe: a 2000-2002 period analysis of EUROCARE-4 data. Lancet Oncol. (2007)
3. Sant, M., Aereleid, T., Berrino, F., et al.: EUROCARE-3: survival of cancer patients diagnosed 1990-1994-results and commentary. Ann. Oncol. 14(S5), v61-118 (2003)
4. Streetly, A, Holland, W.: Population screening and public health. In: Oxford Textbook of Public Health, vol. 3, chapter 12.7. Oxford University Press (2009)
5. G Gatta L Ciccolallo R Capocaccia, et al. 2003 Differences in colorectal cancer survival between European and US populations: the importance of sub-site and morphology Eur. J. Cancer 39 2214 2222 10.1016/S0959-8049(03)00549-5 (Pubitemid 37297748)
6. Council of the European Union 2003 Council recommendation of 2 December 2003 on cancer screening Official J. EU 327 34 38
7. Europe against Colorectal Cancer: Declaration of Brussels (2007). http://www.future-health-2007.com. Accessed Jun 2009
8. European Group for Colorectal Screening 1999 Recommendation to include colorectal cancer screening in public health policy J. Med. Screen. 6 80 81
9. Perry, N., Broeders, M., de Wolf, C., et al. (eds.): European guidelines for quality assurance in breast cancer screening and diagnosis, 4th edn. Office for Official Publications of the European Communities, Luxembourg (2006)
10. Kanavos, P., Schurer, W., Owusu-Apenten, C., et al.: Colorectal cancer in Europe and Australia: challenges and opportunities for the future. London School of Economics, LSE Health, London (2008)
11. European Commission: Cancer screening in the European Union: report on the implementation of the council recommendation on cancer screening-first report. Brussels (2008)
12. Australian Institute of Health and Welfare, Australian Government Department of Health and Aging for the National Bowel Cancer Screening Program: National bowel cancer screening program monitoring report 2007. Cancer series, number 40, Canberra (2008)
13. D Gyrd-Hansen J Sogaard O Kronborg 1998 Colorectal cancer screening: efficiency and effectiveness Health Econ. 7 9 20 10.1002/(SICI)1099-1050(199802) 7:1<9::AID-HEC304>3.0.CO;2-H (Pubitemid 28112231)
14. C Lejeune P Arveux V Dancourt, et al. 2004 Cost effectiveness analysis of fecal occult blood screening for colorectal cancer Int. J. Tech. Assoc. Health Care 20 434 439 (Pubitemid 39491490)
15. C Berchi V Bouvier JM Réaud 2004 Cost effectiveness analysis of two strategies for mass screening for colorectal cancer in France Health Econ. 13 227 238 10.1002/hec.819 (Pubitemid 38292480)
16. CA Stone RC Carter T Vos, et al. 2004 Colorectal cancer screening in Australia: an economic evaluation of a potential biennial screening program using faecal occult blood tests Aust. N. Z. J. Public Health 28 273 282
17. DK Whynes AR Neilson AR Walker, et al. 1998 Faecal occult blood screening for colorectal cancer: is it cost-effective? Health Econ. 7 21 29 10.1002/(SICI)1099-1050(199802)7:1<21::AID-HEC306>3.0.CO;2-9 (Pubitemid 28112232)
18. DK Whynes FOB Nottingham 2004 Screening trial: cost-effectiveness of screening for colorectal cancer: evidence from the Nottingham faecal occult blood trial J. Med. Screen. 11 11 15 10.1258/096914104772950691 (Pubitemid 38365689)
19. P Tappenden J Chilcott S Eggington, et al. 2007 Option appraisal of population based colorectal cancer screening programmes in England Gut 56 677 684 10.1136/gut.2006.095109 (Pubitemid 46662935)
20. BA O'Leary JK Olynyk AM Neville, et al. 2004 Cost-effectiveness of colorectal cancer screening: comparison of community-based flexible sigmoidoscopy with fecal occult blood testing and colonoscopy J. Gastroenterol. Hepatol. 19 38 47 10.1111/j.1440-1746.2004.03177.x (Pubitemid 38130605)
21. J Norum 1998 Prevention of colorectal cancer: a cost-effectiveness approach to a screening model employing sigmoidoscopy Ann. Oncol. 9 613 618 10.1023/A:1008232729664 (Pubitemid 28318193)
22. Hassan, C., Zullo, A., Laghi, A., et al.: Colon cancer prevention in Italy: Cost-effectiveness analysis with CT colonography and endoscopy. Dig. Liver Dis. 39, 242-250 (2007)
23. BJ Denis M Ruetsch P Strentz, et al. 2007 Short term outcomes of the first round of a pilot colorectal cancer screening programme with guaiac based faecal occult blood test Gut 56 1579 1584 10.1136/gut.2007.126037 (Pubitemid 350033197)
24. Bowel Cancer UK: The bowel cancer screening programme: a progress report on the roll-out of screening in England ( http://www.bowelcanceruk.org.uk/home/ about-us/awareness/bowel-screening-program/bowel-cancer-uk-screening-report.pdf ) (2007). Accessed August 2009
25. N Segnan C Senore B Androni, et al. 2005 Randomized trial of different strategies for colorectal cancer: patient response and detection rates J. Natl Cancer Inst. 97 347 357
26. UK Flexible Sigmoidoscopy Screening Trial Investigators 2002 Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK muticentre randomised trial Lancet 359 1291 1300 10.1016/S0140-6736(02) 08268-5 (Pubitemid 34310634)
27. M Zorzi F Falcini C Fedato, et al. 2008 Screening for colorectal cancer in Italy: 2006 survey Epidemiol. Prev. 32 S1 55 68
28. European Commission: Health in the European Union. Special Eurobarometer 272e/Wave 66.2 (2007)
29. Geitona, M., Kanavos, P.: Colorectal cancer management and prevention policies in Greece (this issue)
30. Verastegui, E., Mohar, A.: Colorectal cancer in Mexico: should a middle income country invest in screening or treatment? (this issue)
31. Avkentieva, M.: Colorectal cancer in Russia (this issue)
32. Tatar, M., Tatar, F.: Colorectal cancer in Turkey: current situation and challenges for the future (this issue)
33. Chevreul, K.: Colorectal cancer in France (this issue)
34. Masseria, C.: Colorectal cancer in Italy: a review of current national and regional practices on screening and treatment (this issue)
35. Schurer, W., Kanavos, P.: Evolution of colorectal cancer care in the United Kingdom (this issue)
36. Schulenburg, M.G., Prenzler, A., Schurer, W.: Cancer management and reimbursement aspects in Germany-an overview of colorectal cancer (this issue)
37. Ruszkowski, J.: Colorectal cancer in Poland: undergoing improvements (this issue)
38. Pinto, C.G., Paquete, A.T., Pissarra, I.: Colorectal cancer in Portugal (this issue)
39. Schurer, W.: The current status of colorectal cancer in the Netherlands: directions to the future (this issue)
40. Lopez-Bastida, J., Bellas-Beceiro, B., Quintero-Carrión, E.: The challenge of colorectal cancer prevention in Spain (this issue)
41. Boncz, I., Brodszky, V., Péntek, M., Ágoston, I., Nagy, Z., Kárpáti, K., Kriszbacher, I., Fuszek, P., Gulácsi, L.: The disease burden of colorectal cancer in Hungary (this issue)
42. Vrangbaek, K., Nielsen, M.B.: Colorectal cancer care in Denmark: status and dilemmas (this issue)
43. JM Canard M Debette-Gratien R Dumas, et al. 2005 A prospective national study on colonoscopy and sigmoidoscopy in 2000 in France Gastroenterol. Clin. Biol. 29 17 22
44. National Health Service: Cancer screening programmes. http://www.cancerscreening.nhs.uk/index.html. Accessed Jul 2009
45. JS Terhaar sive Droste ME Craanen JJ Kolkman, et al. 2006 Dutch endoscopic capacity in the era of colorectal screening Neth. J. Med. 64 371 374
46. J Price C Campbell J Sells, et al. 2005 Impact of UK colorectal cancer screening pilot on hospital diagnostic services J. Public Health 27 246 253 10.1093/pubmed/fdi030 (Pubitemid 41298084)
47. D Weller D Coleman R Robertson, et al. 2007 The UK colorectal cancer screening pilot: results of the second round of screening in England Br. J. Cancer 97 1601 1605 10.1038/sj.bjc.6604089 (Pubitemid 350249359)
48. SA Fernando AE Duggan OF Dent, et al. 2007 Colonoscopy capacity in selected New Shouth Wales hospitals Med. J. Aust. 187 249 250
49. CJA Bowles R Leicester C Romaya, et al. 2004 A prospective study of colonoscopy practice in the UK today: are we adequately prepared for national colorectal cancer screening tomorrow? Gut 53 277 283 10.1136/gut.2003.016436 (Pubitemid 38125519)
50. FA Macrae 2007 Providing colonoscopy services for the National Bowel Cancer Screening Program MJA 186 280 281
51. T Shapero J Hoover LF Paszat, et al. 2007 Colorectal cancer screening with nurse-performed flexible sigmoidoscopy: results from a Canadian community-based program Gastrointest. Endosc. 65 640 645 10.1016/j.gie.2006.06. 037 (Pubitemid 46454274)
52. JWW Coebergh 2000 Challenges and pit-falls of mass screening in the European Union Eur. J. Cancer 36 1469 1472 10.1016/S0959-8049(00)00160-X (Pubitemid 30618998)
53. JWW Coebergh 2004 Colorectal cancer screening in Europe: first things first Eur. J. Cancer 40 638 642 10.1016/j.ejca.2003.12.015 (Pubitemid 38326612)
54. French National Society of Gastroenterology. Thesaurus for digestive cancers (Translated from French). http://www.snfge.org/01-Bibliotheque/0G- Thesaurus-cancerologie/publication5/sommaire-thesaurus.asp#1218 (2009). Accessed August 2009
55. Standards, Options and Recommendations. Palliative chemotherapy in patients with metastatic colorectal cancer (Translated from French). http://www.sor-cancer.fr/index.php?tg=fileman&idx=get&inl=1&id= 2&gr=Y&path=Appareil+digestif%2Fcancer +colorectal&file=APC-DIG- Colorectale-Chimio-int.pdf (2003). Accessed August 2009
56. Standards, Options and Recommendations. Perioperative chemotherapy in patients with resectable rectal cancer (Translated from French). http://www.sor-cancer.fr/index.php?tg=articles&topics=65 (2007). Accessed August 2009
57. German Oncology Association. S3 Guidelines for Colorectal Cancer (Translated from German). http://www.dgvs.de/media/Leitlinie.pdf (2008). Accessed August 2009
58. Standards, Options and Recommendations. Recommendations for palliative chemotherapy for patients with metastatic colorectal cancer (Translated from French). http://www.sor-cancer.fr/index.php?tg=articles&topics=44 (2005). Accessed August 2009
59. Schmiegel, W., Pox, C., Reinacher-Schick, A., et al.: S3-guideline "colorectal cancer" (2004/2008). http://www.krebsgesellschaft.de/ download/s3-ll-kolorektales-karzinom-2008.pdf. Accessed Jul 2009
60. Italian Medical Oncology Association (AIOM). Guidelines for the treatment of colorectal cancer (Translated from Italian). http://www.aiom.it/ Attivit%E0+Scientifica/Linee+guida/Tumori+del+colon%2Dretto/1,348,0 (2007). Accessed August 2009
61. Oncoline. National working group on gastrointestinal tumours (Translated from Dutch). http://www.oncoline.nl (2008). Accessed August 2009
62. National Institute for Health and Clinical Excellence: Improving outcomes in colorectal cancers. http://guidance.nice.org.uk/CSGCC/Guidance/pdf/English (2004). Accessed August 2009
63. National Institute for Health and Clinical Excellence: Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer. NICE Technology Appraisal 61. http://guidance.nice.org.uk/TA61/Guidance/pdf/ English (2003). Accessed August 2009
64. National Institute for Health and Clinical Excellence: Capecitabine and oxaliplating in the adjuvant treatment of stage III colon cancer. NICE Technology Appraisal 100. http://guidance.nice.org.uk/TA100/Guidance/pdf/English (2006). Accessed August 2009
65. National Institute for Health and Clinical Excellence: Irintotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer. NICE Technology Appraisal 93. http://guidance.nice.org.uk/TA93/Guidance/pdf/ English (2005). Accessed August 2009
66. National Institute for Health and Clinical Excellence: Bevacizumab and cetuximab for the treatment of metastatic colorectal cancer. NICE Technology Appraisal 118. http://guidance.nice.org.uk/TA118/Guidance/pdf/English (2007). Accessed August 2009
67. National Institute for Health and Clinical Excellence: Laparoscopic surgery for colorectal cancer. NICE Technology Appraisal Guidance 105. http://guidance.nice.org.uk/TA105/Guidance/pdf/English (2006). Accessed August 2009
68. European Society Medical Oncology Working Group: Colon cancer: ESMO clinical recommendations for diagnosis adjuvant treatment and follow-up. Ann. Oncol. 18(S2), ii21-22 (2007)
69. Danish Colorectal Cancer Association: Guidelines for diagnosis and treatment of colorectal cancer (2005). http://www.kirurgisk-selskab.dk/ guidelines/krc/trykklar%20Bog8.pdf. Accessed July 2009
70. European Society Medical Oncology Working Group: Advanced colorectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann. Oncol. 18(S2), ii25-26 (2007)
71. European Society Medical Oncology Working Group: Rectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann. Oncol. 18(S2), ii23-24 (2007)
72. National Comprehensive Cancer Network: NCCN clinical practice guidelines in oncology: colon cancer. V.1.2008 http://www.nccn.org. Accessed Jul 2009
73. National Comprehensive Cancer Network: NCCN clinical practice guidelines in oncology: rectal cancer. V.1.2008 http://www.nccn.org. Accessed Jul 2009
74. National Comprehensive Cancer Network: Colon and rectal cancer: treatment guidelines for patients. Version V (2007)
75. R Bisschops A Wilmer J Tack 2002 A survey on gastroenterology training in Europe Gut 50 724 729 10.1136/gut.50.5.724 (Pubitemid 34407505)
76. P Rivera JP Delorg P Grosclaude, et al. 2004 French medical demography in oncology: demographic futurology for the next 30 years Bull. Cancer 91 271 277
77. DJ Ruiter B Roald J Underwood, et al. 2004 Histopathology training in Europe: a lesson for other specialties? Virchows Arch. 444 278 282 10.1007/s00428-003-0927-7 (Pubitemid 38446441)
78. GLOBOCAN (2002). http://www-dep.iarc.fr/. Accessed Jul 2009
79. L Ciccolallo R Capocaccia MP Coleman, et al. 2005 Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis Gut 54 268 273 10.1136/gut.2004.044214 (Pubitemid 40139245)
80. K Bouhier J Maurel H Lefevre, et al. 2004 Changing practices for diagnosis and treatment of colorectal cancer in Calvados: 1990-1999 Gastroenterol. Clin. Biol. 28 371 376
81. MP de Leon A Pezzi P Benatti, et al. 2009 Survival, surgical management and perioperative mortality of colorectal cancer in the 21-year experience of a specialised registry Int. J. Colorectal Dis. 24 777 788 10.1007/s00384-009-0687- 1
82. S Manfredi AM Benhamiche B Meny, et al. 2001 Population-based study of factors influencing occurrence and prognosis of local recurrence after surgery for rectal cancer Br. J. Surg. 88 1221 1227 10.1046/j.0007-1323.2001.01861.x (Pubitemid 34015607)
83. HS Evans H Moller D Robinson, et al. 2002 The risk of subsequent primary cancers after colorectal cancer in southeast England Gut 50 647 652 10.1136/gut.50.5.647 (Pubitemid 34407491)
84. AM Bouvier M Latournierie V Jooste, et al. 2008 The lifelong risk of metachronous colorectal cancer justifies long-term colonoscopic follow-up Eur. J. Cancer 44 522 527 10.1016/j.ejca.2008.01.007
85. F Guyot J Faivre S Manfredi, et al. 2005 Time trends in the treatment and survival of recurrences from colorectal cancer Ann. Oncol. 16 756 761 10.1093/annonc/mdi151 (Pubitemid 40767096)
86. Clerc, L., Jooste, V., Lejeune, C., et al.: Cost of care of colorectal cancers according to health care patterns and stage at diagnosis in France. Eur. J. Health Econ. (2007)
87. Australian Cancer Network Colorectal Cancer Guidelines Revision Committee: Guidelines for the prevention, early detection and management of colorectal cancer. The Cancer Council Australia and Australian Cancer Network, Sydney. http://www.cancer.org.au//File/HealthProfessionals/ Clinical%20Guidelines/CRCguidelinesTitleExecSummary.pdf (2005). Accessed August 2009